Cas 16679-58-6 Anti Aging Peptides , 99% Purity Ddavp Desmopressin Acetate

Desmopressin Acetate​ Description

Desmopressin (trade names: DDAVP, DesmoMelt, Minirin, Minirin Melt, Octim, Stimate) is a synthetic replacement for vasopressin, the hormone that reduces urine production. It may be taken nasally, intravenously, or as an oral or sublingual tablet. Physicians prescribe desmopressin most frequently for treatment of diabetes insipidus, bedwetting, or nocturia.

How Does Desmopressin Acetate Work

Desmopressin Acetate can make the clinical treatment of invasive or diagnostic surgery when the bleeding time is shortened or normalized, or due to uremia, cirrhosis, congenital or drug-induced platelet dysfunction, and unknown etiology of bleeding time is too long The patient's blood is under control.
This product can be used to test the dose of positive reactions in patients with mild hemophilia and hemophilia patients with small surgery bleeding control or prevention. For special cases, even for the treatment and prevention of moderate disease patients. Diabetes insipidus: adult 20 ~ 40ug / d; children 10 ~ 20ug / d, divided into 1 to 3 times taking. Enuresis: 10 ~ 40ug / d, before going to bed with. Kidney concentration test: adult 40ug, 1 year old children 10 ~ 20ug. Treatment of bleeding or preoperative bleeding prevention: intravenous 0.3ug / kg.

Benefits Of Desmopressin Acetate

Control bleeding or invasive surgery before the prevention of bleeding: 0.3ug / kg body weight, subcutaneous administration or diluted with normal saline to 50-100ml, intravenous infusion in 15-30 minutes. If the efficacy was positive, the initial dose interval 6-12 hours repeated administration 1-2 times, further repeated administration may reduce the efficacy.

The concentration of VIII: C in hemophilia patients is estimated to be the same as that of factor VIII, and the concentration of VIII: C should be monitored regularly during the period of administration, since the efficacy of repeated administration after treatment in some cases But reduced. If the intravenous infusion of the drug did not make plasma VIII; C concentration to achieve the desired increase, should be added with VIII factor concentrate for treatment. Treatment of hemophilia patients should be based on the results of each patient coagulation test to determine the treatment program.

Side Effects
Fatigue, headache, nausea and stomach pain. A reduction in blood pressure, accompanied by reflex tachycardia and facial flushing. dizziness. Treatment of water intake if the restrictions, it may lead to water retention slip, and associated with symptoms, such as sodium decreased, weight gain.